CSF Tau Biomarker-guided Development of Hsp90 Inhibitors for Alzheimer's Disease
CSF Tau 生物标志物引导开发治疗阿尔茨海默病的 Hsp90 抑制剂
基本信息
- 批准号:8311461
- 负责人:
- 金额:$ 20.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-09-01 至 2013-08-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAffectAffinityAlzheimer&aposs DiseaseAmyloidBindingBiochemicalBiological AssayBiological MarkersBrainCell DeathCell modelCellsCerebrospinal FluidChromosomes, Human, Pair 17ClinicalClinical TrialsCognitionCommunicationComplexComputer SimulationCyclin-Dependent KinasesDementiaDependenceDepositionDevelopmentDiseaseDisease OutcomeDisease ProgressionDissociationDoseFrontotemporal DementiaGenesGlycogen Synthase Kinase 3GoalsGrantHSP 90 inhibitionHeat-Shock Proteins 90In VitroInheritedInhibitory Concentration 50LinkMeasuresMedicalMicrotubulesMolecular ChaperonesMolecular TargetMutationNerve DegenerationNeurodegenerative DisordersNeurofibrillary TanglesNeuronsNormal CellParkinsonian DisordersPathogenesisPathway interactionsPatientsPenetrationPeptidesPharmaceutical PreparationsPhosphorylationPhosphotransferasesPlayPopulation StudyProteinsRelative (related person)ResearchRoleSenile PlaquesSeveritiesSolubilityStructureStructure-Activity RelationshipSystemTestingTherapeuticTherapeutic AgentsTissuesabnormally phosphorylated tauabstractingaddictionbasebrain tissuechemical propertycytotoxicitydesigndrug developmentdrug discoveryheat-shock factor 1improvedin vivoinhibitor/antagonistmild neurocognitive impairmentneoplastic cellneuroblastoma cellneurofibrillary tangle formationnovelnovel strategiesoncologyphysical modelscaffoldsecretasetau Proteinstau aggregationtau mutationtau phosphorylationtau-1tumor
项目摘要
DESCRIPTION (provided by applicant): Research & Related Other Project Information Item 7. Project Summary/Abstract Neurodegeneration in Alzheimer's disease (AD) may result from deposition of A¿ as plaques in brain tissue. However, less effort has been made to elucidate the role of tau- containing neurofibrillary tangles (NFTs) in AD. Accumulating evidence suggests that tau containing NFTs is an important component in the initiation and progression of AD and other neurodegenerative diseases. In this proposal the tau pathway is targeted through inhibition of the molecular chaperone Hsp90 as a promising new approach to affect the disease progression of AD. The goal of this grant is to optimize two structurally distinct scaffolds aided by in silico modeling and physical-chemical property predictions in order to generate novel brain permeable Hsp90 inhibitors as AD therapeutics. Subsequently, these compounds will be clinically developed for the treatment of AD using CSF biomarkers, as well as improved cognition, for in vivo efficacy determinations.
PUBLIC HEALTH RELEVANCE: Research & Related Other Project Information Item 8. Project Narrative This research is focused on identifying potential drug candidates to treat Alzheimer's disease (AD) and in this way it addresses NIA's priorities to support research on health and disease in the aged. Furthermore, this project targets the tau pathway as a promising new approach to affect the disease progression of AD.
描述(由申请人提供):研究及相关的其他项目信息项目7。项目摘要/摘要阿尔茨海默病(AD)的神经退行性变可能是由于A?在脑组织中沉积为斑块。然而,较少的努力已经阐明了含tau蛋白的神经元缠结(NFT)在AD中的作用。越来越多的证据表明,含tau的NFT是AD和其他神经退行性疾病的起始和进展中的重要组分。在该提议中,通过抑制分子伴侣Hsp 90靶向tau通路,作为影响AD疾病进展的有前途的新方法。该资助的目标是优化两种结构不同的支架,并通过计算机建模和物理化学性质预测来辅助,以产生新型脑渗透性Hsp 90抑制剂作为AD治疗剂。随后,这些化合物将在临床上开发用于使用CSF生物标志物治疗AD,以及改善认知,用于体内疗效测定。
公共卫生相关性:研究及相关其他项目信息项目8。该研究的重点是确定治疗阿尔茨海默病(AD)的潜在候选药物,并以这种方式解决NIA的优先事项,以支持老年人健康和疾病的研究。此外,该项目将tau通路作为影响AD疾病进展的一种有前途的新方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(2)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gregory D Cuny其他文献
BMP type I receptor inhibition reduces heterotopic ossification
骨形态发生蛋白 I 型受体抑制可减少异位骨化
- DOI:
10.1038/nm.1888 - 发表时间:
2008-11-30 - 期刊:
- 影响因子:50.000
- 作者:
Paul B Yu;Donna Y Deng;Carol S Lai;Charles C Hong;Gregory D Cuny;Mary L Bouxsein;Deborah W Hong;Patrick M McManus;Takenobu Katagiri;Chetana Sachidanandan;Nobuhiro Kamiya;Tomokazu Fukuda;Yuji Mishina;Randall T Peterson;Kenneth D Bloch - 通讯作者:
Kenneth D Bloch
Gregory D Cuny的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gregory D Cuny', 18)}}的其他基金
IMPDH inhibitors for the treatment of Cryptosporidium infections
IMPDH 抑制剂用于治疗隐孢子虫感染
- 批准号:
9305043 - 财政年份:2016
- 资助金额:
$ 20.08万 - 项目类别:
IMPDH inhibitors for the treatment of Cryptosporidium infections
IMPDH 抑制剂用于治疗隐孢子虫感染
- 批准号:
9156503 - 财政年份:2016
- 资助金额:
$ 20.08万 - 项目类别:
Optimizing IMPDH inhibitors for the treatment of cryptosporidiosis
优化 IMPDH 抑制剂治疗隐孢子虫病
- 批准号:
8905204 - 财政年份:2014
- 资助金额:
$ 20.08万 - 项目类别:
Small Molecule Modulators of the Glutamate Transporter for Treatment of ALS
谷氨酸转运蛋白小分子调节剂治疗 ALS
- 批准号:
8294684 - 财政年份:2011
- 资助金额:
$ 20.08万 - 项目类别:
Small Molecule Modulators of the Glutamate Transporter for Treatment of ALS
谷氨酸转运蛋白小分子调节剂治疗 ALS
- 批准号:
8129019 - 财政年份:2011
- 资助金额:
$ 20.08万 - 项目类别:
Small molecule probes for elucidating necrotic cell death mechanisms
用于阐明坏死细胞死亡机制的小分子探针
- 批准号:
8286520 - 财政年份:2009
- 资助金额:
$ 20.08万 - 项目类别:
National Center for Drug Discovery in Neurodegeneration
国家神经退行性疾病药物发现中心
- 批准号:
7648107 - 财政年份:2005
- 资助金额:
$ 20.08万 - 项目类别:
相似海外基金
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 20.08万 - 项目类别:
Training Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 20.08万 - 项目类别:
Standard Grant
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 20.08万 - 项目类别:
Standard Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 20.08万 - 项目类别:
Fellowship
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 20.08万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 20.08万 - 项目类别:
Research Grant
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 20.08万 - 项目类别:
Studentship
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 20.08万 - 项目类别:
Operating Grants
New Tendencies of French Film Theory: Representation, Body, Affect
法国电影理论新动向:再现、身体、情感
- 批准号:
23K00129 - 财政年份:2023
- 资助金额:
$ 20.08万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Protruding Void: Mystical Affect in Samuel Beckett's Prose
突出的虚空:塞缪尔·贝克特散文中的神秘影响
- 批准号:
2883985 - 财政年份:2023
- 资助金额:
$ 20.08万 - 项目类别:
Studentship